The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · Pricing

Cost per milligram, computed honestly across formats

B
BirkelandTL3Regular20 Nov 2024#1

Posting this under the heading it deserves: Cost per milligram, computed honestly across formats Everything below is what sits behind that.

Documenting an access outcome, dated, because everything in this category expires.

As of May 2026, in my region, the position is as described below. I have linked the primary source rather than a summary of it, because the summaries are consistently a year behind.

If anyone can confirm or contradict this for their own region, please date your answer. An undated claim in this category is worse than no claim.

46 likes 20mo
VT
vial_tableTL2Member7 Jan 2025#2

Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be compared on price per milligram alone because dead volume, wastage, and number of doses actually obtainable differ.

0 likes 19mo
DV
d.vestergaardTL2 Moderator10 Feb 2025#3
Birkeland, post #1: Posting this under the heading it deserves: Cost per milligram, computed honestly across formats Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category expires. As of May 2026, in my region, the position is as described below. I have linked the primary source rather than a… Go to post

This follows post #2 rather than contradicting it.

Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some proteins; incretin agonist pricing might follow.

4 likes in reply to #1 18mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Comparing prices across jurisdictions without misleading yourself
Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
LCGFVTPOO+78 83 33k 1mo
Pen wastage and its effect on real cost
Pen wastage and its effect on real cost Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what determines…
WVGPFYWMG+29 33 19k 21mo
Cost per delivered dose, which is the number that matters
Cost per delivered dose, which is the number that matters — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what…
MYFTATRFAD+54 59 30k 4mo
Manufacturer assistance programmes and their eligibility rules
On the subject in the title: Manufacturer assistance programmes and their eligibility rules Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
TPHFRMIBCR+37 42 32k 11d
Revisiting: List price versus negotiated price versus what you pay
Revisiting: List price versus negotiated price versus what you pay — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
VKBVIABDGR+24 28 50k 12mo

Related topics — sharing the tags formulary, cost per milligram, data table

TopicParticipantsRepliesViewsActivity
Where the integrator drew the baseline, and how much it moved the number
Where the integrator drew the baseline, and how much it moved the number — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three…
FNNPMAVKTV+20 24 1.6k 8mo
[2026 update] Comparing prices across jurisdictions without misleading yourself
On the subject in the title: Comparing prices across jurisdictions without misleading yourself Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
SDICP 2 809 23h
Step therapy requirements and how to satisfy them
Posting this under the heading it deserves: Step therapy requirements and how to satisfy them Everything below is what sits behind that. A coverage question with the paperwork detail included, since that is…
APKVVBBNRF+21 25 49k 2mo
Comparing my trajectory with the trial curves, carefully — a second dataset
Comparing my trajectory with the trial curves, carefully — a second dataset — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this that…
OPYMHESTBW+77 81 16k 11h
Pre-registering a personal experiment, seriously — a second dataset
Posting this under the heading it deserves: Pre-registering a personal experiment, seriously — a second dataset Everything below is what sits behind that. I have seen STEP 8 ( JAMA , 2022) cited in support of…
DMVKAFCVCL+60 66 35k 3mo